Search Results - "Luo, Chengjuan"

Refine Results
  1. 1

    Successful Treatment of Pediatric Refractory Burkitt Lymphoma PTLD after Liver Transplantation using Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy by Wang, Tianyi, Feng, Mingxuan, Luo, Chengjuan, Wan, Xinyu, Pan, Ci, Tang, Jingyan, Xue, Feng, Yin, Minzhi, Lu, Dongqing, Xia, Qiang, Li, Benshang, Chen, Jing

    Published in Cell transplantation (2021)
    “…In the immunocompromised setting, recipients of solid-organ or hematopoietic stem-cell transplants carry an increased risk of post-transplant…”
    Get full text
    Journal Article
  2. 2

    TCRαβ-depleted hematopoietic stem cell transplant and third-party CD45RA+ depleted adoptive cell therapy for treatment of post-transplant parvovirus B19 aplastic crisis by Zhang, Manpin, Luo, Chengjuan, Wang, Jianmin, Zhu, Hua, Luo, Changying, Qin, Xia, Huang, Xiaohang, Lin, Yuchen, Chen, Jing

    “…•Persistent B19 infection can lead to aplastic crisis and graft rejection.•TCRαβ-depleted HSCT can treat secondary graft rejection.•The third-party CD45RA+…”
    Get full text
    Journal Article
  3. 3

    PTPN11 mutation with additional somatic alteration indicates unfavorable outcome in juvenile myelomonocytic leukemia: a retrospective clinical study from a single center by Miao, Yan, Li, Benshang, Ding, Lixia, Zhu, Hua, Luo, Changying, Wang, Jianmin, Luo, Chengjuan, Chen, Jing

    Published in European journal of pediatrics (01-03-2020)
    “…Juvenile myelomonocytic leukemia (JMML) is a heterogeneous childhood leukemia. The management of patients with JMML requires accurate assessment of genetic and…”
    Get full text
    Journal Article
  4. 4

    Case Report: Unedited allogeneic chimeric antigen receptor T cell bridging to conditioning-free hematopoietic stem cell transplantation for a child with refractory Burkitt lymphoma by Yang, Xiaomin, Luo, Chengjuan, Qian, Juan, Huang, Xiaohang, Zhang, Jian, Wang, Jianmin, Luo, Changying, Qin, Xia, Li, Benshang, Chen, Jing

    Published in Frontiers in immunology (06-09-2023)
    “…Purpose Burkitt lymphoma (BL) is the most common tumor of non-Hodgkin’s lymphoma (NHL) in children, accounting for about 40% of cases. Although different…”
    Get full text
    Journal Article
  5. 5

    Safety and efficacy of co-administration of CD19 and CD22 CAR-T cells in children with B-ALL relapse after CD19 CAR-T therapy by Li, Wenjie, Ding, Lixia, Shi, Wenhua, Wan, Xinyu, Yang, Xiaomin, Yang, Jing, Wang, Tianyi, Song, Lili, Wang, Xiang, Ma, Yani, Luo, Chengjuan, Tang, Jingyan, Gu, Longjun, Chen, Jing, Lu, Jun, Tang, Yanjing, Li, Benshang

    Published in Journal of translational medicine (22-03-2023)
    “…CD19-targeted chimeric antigen receptor T-cell (CAR-T) therapy has shown remarkable efficacy in treating relapsed or refractory pediatric B-lineage acute…”
    Get full text
    Journal Article
  6. 6

    Outcomes of Anti-CD19 CAR-T Treatment of Pediatric B-ALL with Bone Marrow and Extramedullary Relapse by Wan, Xinyu, Yang, Xiaomin, Yang, Fan, Wang, Tianyi, Ding, Lixia, Song, Lili, Miao, Yan, Wang, Xiang, Ma, Yani, Luo, Chengjuan, Tang, Jingyan, Gu, Longjun, Chen, Jing, Tang, Yanjing, Lu, Jun, Li, Benshang

    Published in Cancer research and treatment (01-07-2022)
    “…Anti-CD19 chimeric antigen receptor T-cell immunotherapy (19CAR-T) has achieved impressive clinical results in adult and pediatric relapsed/refractory (r/r)…”
    Get full text
    Journal Article
  7. 7

    Toxoplasma gondii infection in children after allogeneic hematopoietic stem cell transplantation: A case report and literature review by Luo, Lijuan, Shen, Nan, Chen, Wenjuan, Luo, Chengjuan, Huang, Xiaohang, Jiang, Yuelian, Cao, Qing

    Published in Pediatric investigation (01-09-2021)
    “…ABSTRACT Introduction Toxoplasmosis is a life‐threatening complication after hematopoietic stem cell transplantation (HSCT). However, for several reasons,…”
    Get full text
    Journal Article
  8. 8

    One-Stop No-Edited Allogenic CAR-T Therapy Bridging HSCT to Treat Children with Relapse and Refractory Acute Lymphoblastic Leukemia: A Prospective Clinical Study from a Single Center by Luo, Chengjuan, Tang, Yanjing, Luo, Changying, Huang, Xiaohang, Qin, Xia, Zhu, Hua, Li, Benshang, Chen, Jing

    Published in Blood (02-11-2023)
    “…Object: Chimeric Antigen Receptor T-Cell (CAR-T) therapy has been developed to be the most effective treatment for relapse and refractory(R/R) B-cell acute…”
    Get full text
    Journal Article
  9. 9

    Lianhua Qingwen protects LPS-induced acute lung injury by promoting M2 macrophage infiltration by Li, Shanshan, Feng, Tianyue, Zhang, Yingwen, Shi, Qiqi, Wang, Wanqiao, Ren, Jingyu, Shen, Gangyi, Gu, Haihui, Luo, Chengjuan, Li, Yanxin

    Published in Journal of ethnopharmacology (10-02-2024)
    “…ETHNOPHARMACOLOGICAL RELEVANCETraditional Chinese medicine Lianhua Qingwen (LHQW) was used to treat regular seasonal influenza. In recent years, LHQW exerts…”
    Get full text
    Journal Article
  10. 10

    Further delineation of bone marrow failure syndrome caused by novel compound heterozygous variants of MYSM1 by Li, Niu, Xu, Yufei, Yu, Tingting, Yao, Ruen, Chen, Jing, Luo, Chengjuan, Wang, Jian

    Published in Gene (05-10-2020)
    “…•Identification a novel compound heterozygous variants of MYSM1 in a Chinese patient with bone marrow failure syndrome.•The first report of a pathogenic…”
    Get full text
    Journal Article
  11. 11

    Droplet digital PCR: An effective method for monitoring and prognostic evaluation of minimal residual disease in JMML by Mao, Shengqiao, Lin, Yuchen, Qin, Xia, Miao, Yan, Luo, Changying, Luo, Chengjuan, Wang, Jianmin, Huang, Xiaohang, Zhu, Hua, Lai, Junchen, Chen, Jing

    Published in British journal of haematology (01-06-2024)
    “…Juvenile myelomonocytic leukaemia (JMML) is a rare myeloproliferative neoplasm requiring haematopoietic stem cell transplantation (HSCT) for potential cure…”
    Get full text
    Journal Article
  12. 12

    Metagenomic next-generation sequencing in detecting pathogens in pediatric oncology patients with suspected bloodstream infections by Wu, Jing, Song, Wenting, Yan, Hui, Luo, Chengjuan, Hu, Wenting, Xie, Li, Shen, Nan, Cao, Qing, Mo, Xi, An, Kang, Tao, Yue

    Published in Pediatric research (01-02-2024)
    “…Background Studies on mNGS application in pediatric oncology patients, who are at high risk of infection, are quite limited. Methods From March 2020 to June…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    The efficacy and safety of a homoharringtonine-based protocol for children with acute myeloid leukemia: A retrospective study in China by Tang, Yanjing, Luo, Chengjuan, Shen, Shuhong, Xue, Huiliang, Pan, Ci, Hu, Wenting, Chen, Xiaoxiao, Cai, Jiaoyang, Chen, Jing, Tang, Jingyan

    Published in Pediatric hematology and oncology (01-03-2021)
    “…The standard chemotherapy for acute myeloid leukemia (AML) is usually composed of anthracyclines and cytarabine. We previously reported that homoharringtonine…”
    Get full text
    Journal Article
  16. 16

    The impact of donor full‐length KIR2DS4 in the development of acute and chronic GVHD after unrelated allogeneic HSCT by An, Kang, Li, Benshang, Luo, Changying, Wang, Jianmin, Luo, Chengjuan, Chen, Jing

    Published in Pediatric transplantation (01-09-2020)
    “…Background Killer Ig‐like receptor 2DS4 (KIR2DS4) is the most prevalent activating killer Ig‐like receptor gene. It is divergent and encodes either full‐length…”
    Get full text
    Journal Article
  17. 17

    Disease-specific hematopoietic stem cell transplantation in children with inherited bone marrow failure syndromes by Li, Qian, Luo, Changying, Luo, Chengjuan, Wang, Jianmin, Li, Benshang, Ding, Lixia, Chen, Jing

    Published in Annals of hematology (01-08-2017)
    “…Hematopoietic stem cell transplantation (HSCT) using an optimized conditioning regimen is essential for the long-term survival of patients with inherited bone…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Prognostic factors and outcome of patients undergoing hematopoietic stem cell transplantation who are admitted to pediatric intensive care unit by An, Kang, Wang, Ying, Li, Biru, Luo, Changying, Wang, Jianmin, Luo, Chengjuan, Chen, Jing

    Published in BMC pediatrics (20-08-2016)
    “…There are many studies about the prognosis and possible predictive factors of mortality for pediatric allogeneic hematopoietic stem cell transplantation (HSCT)…”
    Get full text
    Journal Article